Orbital - Vol. 12 No. 3 - July-September 2020
FULL PAPERS

DFT-QTAIM Study of Gold Nanoparticles and Cyclic Peptide as Effective Drug Nanocarriers

Bahareh Khoshbayan
Department of Chemistry, Mashhad Branch, Islamic Azad University, Mashhad, Iran & Research Center for Animal Development Applied Biology, Mashhad Branch, Islamic Azad University
Ali Morsali
Department of Chemistry, Mashhad Branch, Islamic Azad University, Mashhad, Iran, and Research Center for Animal Development Applied Biology, Mashhad Branch, Islamic Azad University, Mashhad
Safar Ali Beyramabadi
Department of Chemistry, Mashhad Branch, Islamic Azad University, Mashhad, Iran, and Research Center for Animal Development Applied Biology, Mashhad Branch, Islamic Azad University, Mashhad
Mohammad Reza Bozorgmehr
Department of Chemistry, Mashhad Branch, Islamic Azad University, Mashhad, Iran, and Research Center for Animal Development Applied Biology, Mashhad Branch, Islamic Azad University, Mashhad
Published September 30, 2020
Keywords
  • AIM analysis,
  • density functional theory,
  • penicillamine,
  • quantum molecular descriptors
How to Cite
(1)
Khoshbayan, B.; Morsali, A.; Beyramabadi, S. A.; Bozorgmehr, M. R. DFT-QTAIM Study of Gold Nanoparticles and Cyclic Peptide As Effective Drug Nanocarriers. Orbital: Electron. J. Chem. 2020, 12, 160-171.

Abstract

In this study, cyclic peptide (CP) with cyclooctaglycine model and gold nanoparticles (AuNP) with Au6 cluster model were used to examin the function of penicillamine (PCA) drug on ten different configurations of cyclic peptide-gold nanoparticles (CPAuNP). Binding energies, quantum molecular descriptors such as electrophilicity power (ω), global hardness (η), and solubility energies were studied in aqueous solution and gas phase at the M06-2X density functional level. The binding energy analysis was performed on (CPAuNP/PCA1-10) structures to determine the most stable structure. The obtained values for solvation energies indicate that CPAuNPs can have an effective performance when used along with PCA drug, which is a major factor in drug delivery. The quantum molecular descriptors reveal that the reactivity of cyclic peptide (CP) and PCA drug increases in (CPAuNP/PCA1-10) structures. AIM calculations for all structures show that intermolecular hydrogen bonding and Au-L (L = H, O, S, C, N) interactions play an important role for this drug delivery system. When the PCA drug is parallel to the CPAuNP carrier, interacting simultaneously with CP and AuNP, the structure is more stable than the structures in which the drug has interactions only with the CP or AuNP.

DOI: http://dx.doi.org/10.17807/orbital.v12i3.1519